Your Article Summary
See Latest Articles(Click the title below to leave the MDLinx Network and go to the Journal's Website)
Statins and cancer risk
American Journal of Medicine, 03/28/08
Karp I et al. - Use of lipophilic statins at sufficiently high dose might be associated with a clinically important reduction in the incidence of cancer.
Methods- Objective was to investigate the relation between lipophilic statin use and cancer occurrence
- Pts (aged >=45 y) and survivors of acute myocardial infarction were included
- High- and low-dose statin use were defined as at or above (below) the statin-specific target dose, for any of the 4 lipophilic statin medications
- 30,076 pts, including high-dose, low dose, and non users were followed for up to 7 y
- Incidence rates of any type of cancer were 13.9, 17.2, and 26.0/1000 person-years in statin high-dose, low-dose, and non-users, respectively
- No significant time-dependence of the effect of statins at either dose was detected
Today in Chemotherapy/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Efficacy of escalated imatinib combined with cytarabine in newly diagnosed patients with chronic myeloid leukemia
Haematologica, 12/18/09
A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer
Investigational New Drugs, 12/18/09
Taurolidine in the prevention and therapy of lung metastases
European Journal of Cardio-Thoracic Surgery, 12/18/09